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Background: Previous reports have suggested that sweat electrolytes may be higher
in adults compared to children, however there are no published data. Diagnosis of
Cystic Fibrosis (CF) in adulthood is well recognised particularly with the increasing
spectrum of the condition. We have determined sweat electrolytes in normal healthy
adults in order to examine the validity of the sweat test in this population.
Methods: Normal healthy adults over 18 years of age were included in the study.
Adults with a positive family history of CF or known carriers were excluded; as
were those with any long term health condition (including CBAVD and chronic
pancreatitis). Sweat was collected using the Macroduct sweat collection method
and the samples were analysed using ion speciﬁc electrode method (as per UK
guidelines).
Results: To date, 60 adults have been enrolled (47 females). The mean (range) age
is 30 y (19 to 63). The majority were Caucasian (53). The mean sweat weight is
43mg (inter quartile range, 31 to 57mg). The mean sweat chloride is 24mmol/L
(range, 8 to 60mmol/L; 99.9th centile, 55mmol/L).
Conclusion: These preliminary data support previous studies that suggest higher
sweat electrolyte levels in normal healthy adults compared to children. Whilst the
sweat test still retains a role in late diagnosis of CF some caution needs to be taken
in the interpretation of equivocal values in the adult population. We aim to enrol
over 200 adults to examine the impact of different ages and generate a normal
reference range for our adult population.
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We report an important and previously unrecognised cause for false positive Sweat
Tests. As part of a diagnostic work up, a 24 month old infant with constant cough
had sweat collected using pilocarpine iontophoresis with the Wescor Macroduct
system. Sodium and chloride concentrations, determined by ion selective methods
using the Beckman DXC analyser, were 93 and 96mmol/L respectively. Two further
samples were analysed the following day using identical collection techniques
and laboratory methods. Results were 15 and 18mmol/L for sodium and 12 and
12mmol/L for chloride. Subsequent enquiry revealed that the original sample had
been collected from a site where 4% w/w amethocaine gel (Ametop) had been
applied and removed.
Ametop is a topical local anaesthetic gel often used in children prior to venepuncture
or venous canulation1. The gel is applied under an occlusive dressing for 30−45
minutes resulting in anaesthesia lasting for 4−6 hours. In addition to the active
ingredient, Ametop contains excipients which give the gel a high sodium and
chloride content. Ametop has previously been reported to cause falsely high sodium
and potassium levels in capillary blood samples2. We are currently conducting
experiments to determine the extent and duration of this effect of Ametop on
electrolyte levels in sweat. Meanwhile, we recommend that sweat for electrolyte
estimation should not be collected from sites where Ametop has been applied
within the previous 24 hours. If contamination is suspected, positive sweat tests
should be repeated at least once or sweat collected simultaneously from more than
one site.
Reference(s)
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Introduction: Ex vivo intestinal current measurement (ICM) in Mini-
Ussingchambers has been established to functionally study the CFTR basic defect
in human rectal suction biopsies. It can be elegantly applied at all age groups for
CF diagnostic purposes in difﬁcult cases with equivocal results in the standard diag-
nostic tests. Aim of this study was to describe reference values and reproducibility
of ICM.
Patients and Methods: A total of n = 574 rectal biopsies from n= 212 individuals
(age 0.4−59 yrs) with PI-CF, PS-CF, excluded CF (including CBAVD) and healthy
control were included into analysis. 2−4 biopsies per patient were compared with
respect to basal transepithelial tissue resistance (Rte), basal potential difference
(PD), basal short-circuit current (Isc) and the Isc responses to stimulation with
amiloride, carbachol, cAMP+forskolin and histamine after DIDS according to a
standardised protocol (de Jonge 2004).
Results: We determined ICM reference values for the groups of PI-CF (Isc
23.4±18.1mA/cm2, DIsc carb 0.4±3.6, DIsc cAMP/forsk 2.0±2.9, DIsc hista
−3.1±4.6), PS-CF (Isc 45.6±31.5, DIsc carb 3.4±6.8, DIsc cAMP/forsk 8.0±10.4,
DIsc hista 6.3±10.8), and healthy control (Isc 39.0±26.1, DIsc carb 27.3±7.1, DIsc
cAMP/forsk 15.2±10.6, DIsc hista 27.4±15.2). Rte and DIsc amil differed not
between the groups. Mean CV were: Rte 0.29, PD 0.48, Isc 0.49, DIsc amil 0.76,
DIsc carb 0.59, DIsc cAMP/forsk 0.64, DIsc hista 0.80.
Conclusion: This ﬁrst comprehensive analysis of ICM reference values and repro-
ducibility provides the basis for the method as routine diagnostic tool in equivocal
cases. Moreover, it may be a useful outcome parameter for future preclinical trials
aiming to rescue the CFTR basic defect.
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Background: Nasal Potential Difference (NPD) measurement is an electrophysi-
ological test that assesses Cystic Fibrosis Transmembrane Conductance Regulator
(CFTR) activity and is a recognized diagnostic tool in CF. The aim of this study is
to assess the long term follow up in patients in whom the nasal PD test was pivotal.
Methods: We performed a follow up study on 70 patients with Questionable CF
(QCF) who were divided previously into two groups according to their NPD results:
patients who were likely to have CF (QCF-CF) (n = 24), and those who were likely
not to have CF (QCF-non CF), (n = 46).
Results: 60 out of 70 patients were available for study 5−8 years after initial
NPD. 16 patients in the QCF-CF group were being followed up at CF Centers as
opposed to 1 in the QCF-non CF group (p< 0.01). 7 patients from the QCF-CF
group developed sinusitis during the follow up years compared to none from the
QCF-non CF group. During the years of the follow up, 17 QCF-non CF patients
were diagnosed with other medical conditions that could explain their previous
symptoms. On repeated NPD measurement in the QCF-CF group only, the results
were similar to the original test.
Conclusions: This study supports the diagnostic role of NPD measurement. Larger
cohort studies are required for conﬁrmation.
